Time & location: 11:00 AM ET, Virtual
The clinical trial landscape continues to evolve at a rapid pace. New biomarker detection technologies are driving breakthroughs to earlier discoveries and more sensitive diagnostics. With early detection, biomarker testing research can advance disease understanding and management in areas of care such as neurology, oncology, immunology, cardiology, and infectious disease.
Join this webinar to:
- Learn solutions to demanding clinical timelines
- Explore cutting-edge biomarker technologies and their impact on clinical trials
- Gain insights on leveraging biomarkers to advance disease understanding and management
Speaker
Mingwei Zhao, Ph.D.
Sr. Director of Accelerator Services, Quanterix
Mingwei Zhao is an expert in immunoassay development and biomarker research. He began his career at Harvard University, focusing on gene expression and immune responses. At Quanterix Corporation, he advanced Simoa technology and developed ultrasensitive immunoassays. Now, as Senior Director of Lab Services, he oversees custom assay development and manages external relationships. Zhao holds a Bachelor’s in Biology from Wuhan University and a Ph.D. in Molecular Biology and Biochemistry from the Chinese Academy of Sciences.
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Ultrasensitive Neuroimmune Biomarker Measurement for Translational Research and Therapeutic Development
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…